American Heart Association News Tips
Arteriosclerosis, Thrombosis and Vascular Biology 2012 Scientific Sessions
April 18-20, 2012, Chicago Hilton, Chicago, Ill.
NOTE: EMBARGO TIMES ARE LISTED IN CENTRAL TIME (CT) AND EASTERN TIME (ET). ALL TIPS ARE EMBARGOED UNTIL TIME OF PRESENTATION OR 3 P.M. CT/4 P.M. ET EACH DAY, WHICHEVER COMES FIRST.
Embargoed for: 8 a.m. CT/9 a.m. ET
Abstract 418 – Depression linked to greater risk of peripheral artery disease
CHICAGO, April 20, 2012 (GLOBE NEWSWIRE) -- Depression may be associated with an increased risk of arterial narrowing in the legs and pelvis, a condition known as peripheral artery disease (PAD), according to research presented at the American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology 2012 Scientific Sessions in Chicago.
While experts know that depression is a risk factor for constricted heart arteries, its effect on PAD is uncertain. Researchers used data from 1,024 men and women in the Heart and Soul Study and followed them for about seven years.
At the study's start, 12 percent of participants with depression had PAD, compared to seven percent of patients without depression who had PAD. Similarly, nine percent of depressed patients and six percent of those without depression had PAD-related events during the seven-year follow-up.
These findings demonstrate the importance of depression screening and treatment for PAD patients, according to the researchers.
Author disclosures are on the abstracts.
The American Heart Association logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=9940
Statements and conclusions of study authors that are presented at American Heart Association scientific meetings are solely those of the study authors and do not necessarily reflect association policy or position. The association makes no representation or warranty as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at www.heart.org/corporatefunding.
NR12-1058 (ATVB 2012/ Tip Sheet)
Additional resources, including multimedia, is available on the right column of this link:
http://newsroom.heart.org/pr/aha/_prv-depression-linked-to-greater-risk-231924.aspx
For more information, contact Darcy Spitz at Darcy.Spitz@heart.org; (212) 878-5940 or the American Heart Association National Communications office in Dallas at (214) 706-1173. For public inquiries, call (800) AHA-USA1 (242-8721). http://www.heart.org and http://www.strokeassociation.org.